Request Appointment
160 East 53rd StreetNew York, NY 10022
Overview of Dr. Diamond
Dr. Eli Diamond is a neurologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 18 years. He is one of 62 doctors at Memorial Sloan Kettering Cancer Center who specialize in Neurology. He has more than 100 publications and over 500 citings.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2008 - 2011
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2007 - 2008
Albert Einstein College of MedicineClass of 2007
Certifications & Licensure
FL State Medical License 2022 - Present
NY State Medical License 2011 - 2026
NJ State Medical License 2022 - 2025
NC State Medical License 2020 - 2022
MA State Medical License 2009 - 2012
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Anxiety and depression in patients with histiocytic neoplasms and their associated clinical features.Anne S Reiner, Yesne Alici, Denise D Correa, Dana Bossert, Allison M Sigler
Blood Advances. 2025-03-25 - Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, Elke Pfaff, Pouneh Amir-Yazdani
Clinical Cancer Research. 2025-02-03 - The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms.Mali Salmon-Divon, Refael Meyuchas, Ofer Shpilberg, Elimelech Okon, Jamal Benhamida
Leukemia. 2025-02-01
Press Mentions
FDA Approves First Treatment for Patients with All Forms of HistiocytosisJanuary 30th, 2023
High Response Rate in Histiocytic Disease with MEK InhibitionJanuary 3rd, 2018
NCCN Foundation Awards Grants to Five Young InvestigatorsApril 1st, 2016
Grant Support
- Molecular Pathogenesis and Therapy of Systemic Histiocytic NeoplasmsSLOAN-KETTERING INST CAN RESEARCH2021–2026
- Defining Clinical Research Priorities and Strengthening Diversity and Patient-Stakeholder Engagement in Histiocytic DisordersST. JUDE CHILDREN'S RESEARCH HOSPITAL2024
